The current status and perspectives of immunotherapy in pancreatic adenocarcinomas
10.3760/cma.j.issn.1008-1372.2015.12.007
- VernacularTitle:生物免疫治疗在胰腺癌中的现状及展望
- Author:
Jun WANG
;
Shengping LI
- Publication Type:Journal Article
- Keywords:
Pancreatic neoplasms/TH;
Immunotherapy;
Review
- From:
Journal of Chinese Physician
2015;17(12):1790-1793
- CountryChina
- Language:Chinese
-
Abstract:
Pancreatic adenocarcinoma is one of the most highly malignant digestive system cancers,and current therapeutic strategies are often unsatisfactory.It is associated with a high mortality rate because of low resection rate,early metastasis,and poor chemoradiotherapy response.Identification and development of more efficacious therapies is urgently needed.The basic research promoted the development of immunotherapy for pancreatic cancer,and immunotherapy offered encouraging results in some preclinical trials during the last decade.The aim of this review is to summarize the recent advances in immunotherapy and to evaluate the future perspectives of immunotherapy in the treatment of pancreatic adenocarcinoma.
